- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 16.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 16.15M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 16.15M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $4.71M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $3.57M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $6.68M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $26.08M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $30.82M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $21.29M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $19.9M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$36.34M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$30.71M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.32B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.32B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.23B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.23B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.30 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.86 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.30 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.86 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.11M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.83M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $4.4M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$23.58M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $30.11M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $62.98M |